On 18 December 2024, the World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency which can help to safely deliver WHO-recommended ...
MedTest Dx, Inc., an established solution provider for clinical diagnostic testing, is providing a critical tool in the fight against COVID-19 with its Pointe Scientific-branded assay for the highly ...
The practice patterns and outlook of gynecology oncologists in the treatment of pediatric, adolescent and young adults with gynecologic malignancies: A survey study. This is an ASCO Meeting Abstract ...
Baebies has received US Food and Drug Administration (FDA) 510(k) clearance for its rapid, point-of-care test for glucose-6-phosphate dehydrogenase (G6PD) deficiency. The test is run on the FINDER ...
To test tubes, 16 by 100 mm., are added 10 mg. of sodium ascorbate § and 5 mg. of glucose. These tubes are stoppered and may be stored indefinitely at -20°C. A 2.0-ml. aliquot of whole blood ...
We conducted a survey of malaria diagnoses and glucose-6-phosphate dehydrogenase (G6PD) testing in remote areas of Cambodia. Blood specimens from 670 people were collected by the finger-prick method.
New York is expanding testing of newborns in 2022 to include screening for a range of potentially debilitating genetic conditions, with an emphasis on disorders common among certain ethnic and ...
DURHAM, N.C., Nov. 9, 2022 /PRNewswire/ -- Baebies has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its rapid, point-of-care test for glucose-6-phosphate dehydrogenase (G6PD) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results